AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Impact of Infusion Line Change Frequency on Infectious Complications Related to Central Venous Catheters in the ICU - A Randomized Controlled Trial

RecruitingNAAges 18 Years - anyAllUniversity Hospital, Angers
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

In the intensive care unit, patients' care and secure drugs administration require a central venous catheter. These invasive devices can lead to complications, particularly infections. Most preventive recommendations focus on catheter insertion, line handling, and dressings. Few recommendations adress catheter dwell time, which is certainly the main source of infection. Part of the prevention strategy is the regular and systematic replacement of infusion sets , as they may become contaminated during use, mainly through the hands of healthcare professionals. Prolonged use increases the risk of infection. Infusion lines changes involve disconnecting the old sets, discarding infusion devices containing drug residues, and replacing them with new sterile devices. Current international guidelines recommend replacing these sets every 4 days, and the Center for Disease Control and Prevention re

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion criteria * Adult patient * Any ICU patient with a central venous catheter (inserted by venipuncture) in place for less than 72 hours and with an expected dwell time of at least 7 days * Patient affiliated with or covered by a social security system * Patient who has given verbal consent or written consent from a third party or in the event that the patient is unable to give consent. Exclusion Criteria * Patient with a documented bloodstream infection at the time of inclusion * Patient whose central venous catheter has been in place for more than 72 hours * Patient with suspected catheter-related infection * Patient whose study catheter was inserted using a guidewire exchange * Patient previously enrolled in the study during the same ICU stay * Patient whose condition, according to the clinician, does not allow safe placement of a central venous catheter, such as: * Allergy to catheter material * Confirmed deep vein thrombosis at the time of insertion * Inflammatory skin disorder at the insertion site * Patient admitted for extensive burns * Inadequate understanding of the French language * Pregnant, breastfeeding, or postpartum woman * Person deprived of liberty by judicial or administrative decision * Person receiving involuntary psychiatric care * Person under legal guardianship or other legal protection measure
๐Ÿ’Š

What it tests

  • 7-day Infusion set replacement
  • 4-day infusion set replacement
๐Ÿ“

Where

27 sites
La Rรฉunion University Hospital
Saint-Pierre, France
Albi Hospital
Albi, France
Angers University Hospital
Angers, France
Belfort Hospital
Belfort, France
Bourges Hospital
Bourges, France
Caen University Hospital
Caen, France
CH Carcassonne
Carcassonne, France
Chartres Hospital
Chartres, France

โ€ฆand 19 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy